June 12, 2024
Prof. Dr. Sergi X. Trilla joins Achelous Partners as European Representative
|
June 12, 2024
Achelous Partners Advises Curia on its announced sale of a US CDMO site to Siegfried
|
April 22, 2024
Achelous Partners Advises A4P Consulting Ltd on its sale to LabConnect
|
March 25, 2024
Achelous Partners Advises Six Degrees Medical on its sale to Reverba
|
December 13, 2023
Achelous Partners Advises Bio X Cell on its sale to Windjammer Capital
|
November 17, 2023
Achelous Partners Advises Symbio and ProInnovera on their respective sales to Archimed
|
November 8, 2023
Achelous Partners Advises Pharmalog on its sale to Henko Partners to form Astrum
|
January 9, 2023
Achelous Partners Advises Alcedis on its sale to Huma
|
November 9, 2022
Achelous Partners Advises Expression Systems on its sale to ANGUS Chemical Company (a Portfolio Company of Ardian and Golden Gate Capital)
|
October 3, 2022
Achelous Partners Advises Qfix on its sale to CIVCO Radiotherapy (a Portfolio Company of Blue Wolf Capital Partners)
|
July 12, 2022
Achelous Partners Advises Cergentis B.V. on its sale to Solvias (a Portfolio Company of JLL Partners and Water Street Healthcare Partners)
|
July 8, 2022
Achelous Partners Advises proderm GmbH on its sale to SGS
|
June 7, 2022
Achelous Partners Advises SAI MedPartners on its sale to Northlane Capital
|
June 7, 2022
Achelous Partners Advises AusDiagnostics on its sale to R-Biopharm AG
|
November 10, 2021
Achelous Partners Advises Regulatory Compliance Associates on its sale to Sotera Health
|
August 18, 2021
Achelous Partners Advises DRG International on its sale to BioCheck, Inc.
|
August 4, 2021
Achelous Partners Advises bioskin GmbH on its sale to Eurofins Scientific (EPA: ERF)
|
July 23, 2021
Achelous Partners Advises nanoComposix on its sale to Fortis Life Sciences
|
May 20, 2021
Achelous Partners Advises Clinical Outcomes Solutions, a Global Leader in Clinical Outcomes Assessment Research Services, on its sale to Validant (a Portfolio Company of GHO Capital)
|
March 2, 2021
Achelous Partners Advises Diamond Pharma Services on its sale to ProPharma Group (a Portfolio Company of Odyssey Investment Partners)
|
February 23, 2021
Achelous Partners Advises Delphi Genetics on its sale to Catalent
|
January 4, 2021
Dr. Stephan Wnendt and Dr. Katja Neuer join Achelous Partners as European Representatives
|
October 26, 2020
Achelous Partners Advises MD Biosciences, Inc. on its sale to MLM Medical Labs (a Portfolio Company of Great Point Partners)
|
September 21, 2020
Achelous Partners Advises American Laboratory Products Company, Ltd. (ALPCO) on its sale to Ampersand Capital Partners
|
September 10, 2020
Achelous Partners Advises Maetrics LLC on its sale to Regulatory and Quality Solutions LLC (R&Q, a Portfolio Company of DFW Capital Partners)
|
August 26, 2020
Achelous Partners Advises CTK Biotech on its sale to SSI Diagnostica (a Portfolio Company of Adelis Equity Partners)
|
February 26, 2020
Achelous Partners Advises BresMed Health Solutions Ltd. on its sale to Arsenal Capital Partners
|
January 23, 2020
Achelous Partners Advises Statistics Collaborative, Inc. on its sale to WCG (WIRB-Copernicus Group, a Portfolio Company of Leonard Green & Partners and Arsenal Capital Partners)
|
December 6, 2019
Achelous Partners Advises MLM Medical Labs on its sale to Great Point Partners
|
October 28, 2019
Achelous Partners Advises Specialized Medical Services-oncology BV (SMS-oncology) on its sale to Cato Research LLC (a Portfolio Company of JLL Partners and Water Street Healthcare Partners)
|
July 9, 2019
Achelous Partners Advises EuroLyser GmbH on its sale to ArchiMed
|
July 8, 2019
Achelous Partners Advises LifeSpan Biosciences, Inc. on its acquisition of Nordic MUbio
|
March 5, 2019
Achelous Partners Advises Quorum Review IRB on its sale to Advarra (a Portfolio Company of Linden Capital)
|
January 21, 2019
Achelous Partners CoAdvises ProductLife Group on its sale to 21 Invest
|
January 4, 2019
Achelous Partners Advises CoreBiome, Inc. on its sale to OraSure Technologies, Inc. (NASDAQ: OSUR)
|
October 23, 2018
Achelous Partners Advises Pennside Partners Ltd. on its sale to TwoLabs, LLC (a Portfolio Company of Excellere Partners)
|
October 12, 2018
Artur Aira joins Achelous Partners as its European Representative
|
September 25, 2018
Achelous Partners Advises NovaTec Immundiagnostica GmbH on its sale to Eurofins Scientific (EPA: ERF)
|
September 17, 2018
Achelous Partners Advises Thompson Street Capital Partners on its acquisition of LifeSpan Biosciences, Inc.
|
September 6, 2018
Achelous Partners Advises HyTest Ltd. on its sale to Summa Equity
|
July 31, 2018
Achelous Partners Advises Gold Standard Diagnostics, Inc. on its sale to Eurofins Scientific (EPA: ERF)
|
May 23, 2018
Achelous Partners Advises Biovian Oy on its sale to Keensight Capital
|
January 6, 2018
Achelous Partners Advises LifeCodexx on its sale to Eurofins Scientific (EPA: ERF)
|
June 2, 2017
Achelous Partners Advises Coté Orphan, LLC on its sale to QuintilesIMS
|
May 3, 2017
Achelous Partners Advises PharmaCell B.V. on its sale to Lonza Group Ltd.
|
April 25, 2017
Achelous Partners Advises Emergo Group, Inc. on its sale to UL LLC
|
April 21, 2017
Achelous Partners Advises Calbiotech, Inc. on its sale to Transasia Bio-Medicals / Erba Mannheim
|
January 4, 2017
Achelous Partners Advises BioControl Systems Inc. on its sale to Merck KGaA / MilliporeSigma (XETRA: MRK)
|
August 31, 2016
Achelous Partners Advises SPEware Corporation on its sale to Tecan Group (SIX: TECN)
|
July 6, 2016
Achelous Partners Advises Sharps Compliance Corp. (Nasdaq: SMED) on its acquisition of Citiwaste, LLC
|
June 20, 2016
Dr. Jan Boesen discusses M&A strategy and how to best maximize value in a trade sale at BIO-Europe in Stockholm
|
June 16, 2016
Achelous Partners Advises Argos Soditic and CisBio Bioassays on its sale to Abénex
|
December 15, 2015
Achelous Partners Advises Sharps Compliance Corp. (Nasdaq: SMED) on its acquisition of Bio-Team Mobile
|
November 24, 2015
Achelous Partners Advises Abzena plc (AIM: ABZA) on its acquisition of The Chemistry Research Solution LLC (“TCRS”)
|
September 22, 2015
Achelous Partners Advises Kinesis Pharma BV on its sale to Venn Life Sciences Holding Plc (AIM: VENN)
|
August 26, 2015
Achelous Partners Advises DIAsource ImmunoAssays on its sale to Anteo Diagnostics (ASX: ADO)
|
July 20, 2015
Achelous Partners Advises Sharps Compliance Corp. on its acquisition of Alpha Bio/Med Services
|
May 19, 2015
Dr. Jan Boesen joins Achelous Partners, LLC as its European Representative
|
March 31, 2015
Achelous Partners Advises Ansell Limited on its acquisition of Microgard Ltd.
|
August 18, 2014
Achelous Partners advises Valeant Pharmaceuticals (NYSE: VRX) on its acquisition of ophthalmology and orthopedic assets from Croma Pharma GmbH
|
July 30, 2014
Achelous Partners Advises IBL International Holding BV on its sale to Tecan Group (SIX: TECN)
|
July 14, 2014
Achelous
Partners CoAdvises
Phlexglobal Limited on its sale to
Bridgepoint Development Capital
|
June 18, 2014
Achelous Partners Advises Spectris plc (LSE: SXS) on its acquisition of La Corporation Scientifique Claisse
|
April 23, 2014
Achelous
Partners CoAdvises
Pharmalink Consulting on its sale to
Genpact (NYSE: G)
|
August 19, 2013
Achelous
Partners Advises Kirkegaard & Perry Laboratories (KPL)
on its sale to SeraCare Life Sciences
|
August 9, 2013
Achelous
Partners Advises Austofix Group Limited on the sale of its
orthopedic reconstruction business to Amplitude, an Apax Partners company
|
July 23, 2013
Achelous
Partners Advises Matrical Bioscience Inc on its sale to
Brooks Automation (NASDAQ: BRKS)
|
July 9, 2013
Achelous
Partners Advises The Anson Group LLC on its sale to
Navigant Consulting (NYSE: NCI)
|
July 8, 2013
Achelous
Partners Advises Kreatech Diagnostics on its sale to Leica
Biosystems/Danaher (NYSE: DHR)
|
May 22, 2013
Achelous
Partners Advises Triangle Biomedical Sciences Inc on its
sale to General Data
|
August 29, 2012
Achelous
Partners Advises JSW Life Sciences GmbH on its sale to
QPS LLC
|
March 13, 2012
Achelous
Partners Advises Valeant Pharmaceuticals International
Inc (NYSE: VRX) on its acquisition of assets from Gerot Lannach
|
December 23, 2011
Achelous
Partners Advises Ansell Ltd (ASX: ANN) on its
investment in Lakeland Industries Inc
|
August 30, 2010
Achelous
Partners Advises EnviroLogix Inc on its sale to EnsignBickford
Industries Inc
|
February 1, 2010
Achelous
Partners Advises Finnzymes Oy on its sale to Thermo
Fisher Scientific Inc (NYSE: TMO)
|
December 18, 2009
Achelous
Partners Advises BTG plc (LSE: BGC) on the
licensing of its ReGel® drug delivery system for ophthalmic indications to Allergan Inc
|
October 23, 2009
Achelous
Partners Advises AnaSpec Inc on its sale to Eurogentec
SA
|
August 28, 2009
Achelous
Partners Advises BTG plc (LSE: BGC) on the sale of its
HySolv™ drug delivery technology to Novartis Pharma AG for up to US$10 million
|
January 6, 2009
Achelous
Partners Advises Labcoat Ltd on its sale to Boston
Scientific Corp (NYSE: BSX)
|
December 8, 2008
Achelous
Partners Advises Affymetrix Inc (NASDAQ: AFFX) on
its acquisition of Panomics Inc for a total consideration of US$73 million
|
July 25, 2008
Achelous
Partners Advises Biocompatibles (LSE: BII) on its
acquisition of BrachySciences Inc and its affiliated companies for a total
consideration of up to US$22 million
|
December 24, 2007
Achelous
Partners Advises Sigma Pharmaceuticals Ltd (ASX:
SIP) on its acquisition of Orphan Holdings Pty Ltd for a total consideration of A$130
million
|
October 8, 2007
Achelous
Partners Advises Panbio Ltd (ASX: PBO) on its sale to
Inverness Medical Innovations, Inc (AMEX: IMA) for a total consideration of A$41
million
|
May 4, 2007
Achelous
Partners Advises Ansell Ltd (ASX: ANN) on its acquisition of
Fabrica de Artefatos de Látex Blowtex Ltda of Brazil
|
December 21, 2006
Achelous
Partners Advises GeneMedix plc (LSE: GMX) on its
Proposed Restructuring involving a £32.1 million Proposed Strategic Investment by
Reliance Life Sciences Pvt Ltd, part of the Reliance Group, India's Largest Private
Sector Enterprise
|
December 21, 2006
Achelous
Partners has been Appointed to Act as Financial
Advisor to Panbio Limited (ASX: PBO), an International Medical Diagnostics
Company
|
November 27, 2006
Achelous
Partners Advises Novozymes (CPSE: NZYM B) on its
acquisition of GroPep Ltd (ASX: GRO) for A$100 million
|
July 7, 2006
Achelous
Partners Advises Novozymes (CPSE: NZYM B) on its
acquisition of Delta Biotechnology Ltd from the sanofiaventis
group
|
October 19, 2005
Achelous
Partners has been Appointed to Act as Financial
Advisor to CogState Ltd (ASX: CGS), a Melbourne based Clinical IT Company
|
October 6, 2005
Achelous
Partners has been Appointed to Act as Financial Advisor
to GeneMedix plc (LSE: GMX), a UK Biopharmaceutical Company, and its
Restructuring Program
|
January 21, 2005
Achelous
Partners Named Frost & Sullivan Pharmaceuticals BuySide
M&A Advisor of the Year
|
October 20, 2004
Achelous
Partners Advises Gribbles Group Ltd. (ASX: GGL) on its
sale to Healthscope Ltd. Bid
|